By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Immunome Inc is a biopharmaceutical company engaged in the discovery and development of novel antibody-based drugs. The company's proprietary discovery platform identifies novel therapeutic antibodies and their targets by leveraging highly educated components of the immune system, memory B cells, from patients who have learned to fight off their disease. It is developing treatments for treating cancer and other infectious diseases.

Contact Information

Website: www.immunome.com
Email: investors@immunome.com
Main Phone: +1 610 321-3700
Address: 665 Stockton Drive
Address 2: Suite 300
State: PA
City / Town: Exton
Country: US
Postal Code: 19341

Issuer Information

Exchange: NSC
CEO: Purnanand D. Sarma
Employees: 23
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A